Economic impact with home delivery of chemotherapy to pediatric oncology patients

Annals of Pharmacotherapy

Volumn 31, Issue 2, 1997, Pages 140-148

  Holdsworth, Mark T ^a   Raisch, Dennis W ^b,c   Chavez, Cathy M ^c   Duncan, Marilyn H ^c,d   Parasuraman, T V ^e   Cox, Fred M ^e  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b University of New Mexico   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IFOSFAMIDE; MESNA; METHOTREXATE; METHYLPREDNISOLONE; ONDANSETRON; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HOME CARE; HOME DELIVERY; HOSPITAL ADMISSION; HOSPITAL CHARGE; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; VOMITING;

EID: 0031019703     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100201     Document Type: Article

References (35)

1. Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G, et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986;4:1732-9.
2. Miser JS, Kinsella TJ, Triche TJ, Tsokos M, Forquer R, Wesley R, et al. Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance. J Clin Oncol 1988;6:484-90.
3. Frei E III, Bickers JN, Hewlett JS, Lane M, Leary WV, Talley RW. Dose schedule and antitumor studies of arabinosylcytosine (NSC-63878). Cancer Res 1969;29:1325-32.
4. Capizzi RL, Poole M, Cooper MR, Richards F II, Stuart JJ, Jackson DV, et al. Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. Blood 1984;63:694-700.
5. Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 1982;96:133-9.
6. Morgan LR, Harrison EF, Hawke JE, Hunter HL, Costanzi JJ, Plotkin D, et al. Toxicity of single vs. fractionated-dose ifosfamide in non-small cell lung cancer: a multicenter study. Semin Oncol 1982;9(suppl 1):66-70.
7. Hill JM, Loeb E, MacLellan A, Hill NO, Khan A, King JJ. Clinical studies of platinum coordination compounds in the treatment of various malignant diseases. Cancer Chemother Rep 1975;59:647-59.
8. Pitman SW, Frei E. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat Rep 1977;61:695-701.
9. Bleyer WA. Clinical pharmacology of methotrexate. Cancer 1978;41:36-51.
10. Chan H, Evans WE, Pratt CB. Recovery from toxicity associated with high-dose methotrexate: prognostic factors. Cancer Treat Rep 1977;61:797-804.
11. Marshall G, Kerr S, Vowels M, O'Gorman-Hughes D, White L. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone. J Pediatr 1989;115:156-60.
12. Dorr RT, Von Hoff DD. Mesna. In: Dorr HT, Von Hoff DD, eds. Cancer chemotherapy handbook. 2nd ed. Norwalk, CT: Appleton and Lange, 1994:687.
13. Howrie DL, Felix C, Wollman M, Juhl RP, Blatt J. Metoclopramide as an antiemetic agent in pediatric oncology patients. Drug Intell Clin Pharm 1986;20:122-4.
14. Allen JC, Gralla R, Reilly L, Kellick M, Young C. Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. J Clin Oncol 1985;3:1136-41.
15. Terrin BN, McWilliams NB, Maurer HM. Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapy. J Pediatr 1984;104:138-40.
16. Jayabose S, Escobedo V, Tugal O, Nahaczewski A, Donohue P, Fuentes V, et al. Home chemotherapy for children with cancer. Cancer 1992;69:574-9.
17. Lange BJ, Burroughs B, Meadows AT, Burkey E. Home care involving methotrexate infusions for children with acute lymphoblastic leukemia. J Pediatr 1988;112:492-5.
18. Barton Burke M, Wilkes GM, Berg D, Bean CK, Ingwersen K. Cancer chemotherapy: a nursing process approach. Boston: Jones and Bartlett, 1991.
19. Zimo DA, Gaspar M, Akhter J. The efficacy and safety of home nebulizer therapy for children with asthma. Am J Dis Child 1989;143:208-11.
20. Donati MA, Guennette G, Auerbach H. Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease. J Pediatr 1987;111:28-33.
21. Rabiner SF, Telfer MC. Home transfusion for patients with hemophilia- A. N Engl J Med 1970;283:1011-5.
22. Jennings P. Learning through experience: an evaluation of 'Hospital at Home'. J Adv Nurs 1994;19:905-11.
23. Gropper E. Promoting health by promoting comfort. Nurs Forum 1992;27:5-8.
24. Holdsworth MT, Raisch DW, Duncan MH, Chavez CM, Leasure MM. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia. Ann Pharmacother 1995;29:16-21.
25. Rehm SJ, Weinstein AJ. Home intravenous antibiotic therapy: a team approach. Ann Intern Med 1983;99:388-92.
26. Grizzard MB, Harris G, Karns H. Use of parenteral antibiotic therapy in a health maintenance organization. Rev Infect Dis 1991;13(suppl 2):S174-9.
27. Eisenberg JM, Kitz DS. Savings from outpatient antibiotic therapy for osteomyelitis. Economic analysis of a therapeutic strategy. JAMA 1986;255:1584-8.
28. Stommel M, Given CW, Given BA. The cost of cancer home care to families. Cancer 1993;71:1867-74.
29. Close P, Burkey E, Kazak A, Danz P, Lange B. A prospective, controlled evaluation of home chemotherapy for children with cancer. Pediatrics 1995;95:896-900.
30. Haggerty MC, Stockdale-Woolley R, Nair S. Respi-care. An innovative home care program for the patient with chronic obstructive pulmonary disease. Chest 1991;100:607-12.
31. Knowelden J, Westlake L, Wright K, Clarke S. Peterborough Hospital at Home: an evaluation. J Public Health Med 1991;13:182-8.
32. Roila F, Tonato M, Cognetti F, Cortesi E, Favalli G, Marangolo M, et al. Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 1991;9:675-8.
33. Roila F. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination. Oncology 1993;50;163-7.
34. Gerson LW, Collings JF. A randomized controlled trial of home care: clinical outcomes for five surgical procedures. Can J Surg 1976;19:519-23.
35. Mitchell JB. Patient outcomes in alternative long-term care settings. Med Care 1978;16:439-52.